RAVULIZUMAB
Clinical Indication
Treating atypical haemolytic uraemic syndrome (aHUS)
Comments
Only for use in specialist centres or in secondary care under an agreed tertiary centre as per NICE TA710.
Date of classification
September 2021
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.